Flyp Nebulizer

Fairfield, United States Founded: 2017 • Age: 9 yrs
Portable nebulizers for asthma and COPD treatment are developed.

About Flyp Nebulizer

Flyp Nebulizer is a Healthcare company based in Fairfield (United States) founded in 2017 by Ralph Finger. Portable nebulizers for asthma and COPD treatment are developed. Flyp Nebulizer has raised $4.61 million across 2 funding rounds from investors including HighCape Capital, Connecticut Innovations and Stonehenge Capital. The company has 24 employees. Its focus areas include Life Sciences, Pulmonology, Medical Devices and Therapeutic Devices. Its legal entity is CONVEXITY SCIENTIFIC INC. Its competitors include Aerin Medical, SmartVest and TurnCare; 2 of its 3 listed competitors have raised funding.

Company details

Flyp Nebulizer was founded in 2017 and is based in Fairfield, United States. Portable nebulizers powered by HypersoniQ technology are developed by the company for asthma and COPD management. These pocket-sized, USB-rechargeable devices are designed to dispense medication efficiently. Operations focus on medical device innovation within the respiratory health sector, serving users requiring on-the-go treatment options.

  • Headquarters Fairfield, United States
  • Employees 24
  • Founders Ralph Finger
  • Sectors
    Healthcare
  • Email
    β€’β€’β€’β€’β€’β€’β€’β€’
  • Website flypnebulizer.com
  • Social LinkedIn X Facebook
  • Legal Name Convexity Scientific Inc.
Operational Areas
Key Metrics
  • Total Equity Funding
    $4.61M (USD)

    in 2 rounds

  • Latest Funding Round
    $613.29K (USD), Series B

    Feb 2026

  • Investors
  • Employee Count
    24

Funding Insights of Flyp Nebulizer

Flyp Nebulizer has successfully raised a total of $4.61M across 2 strategic funding rounds. The most recent funding activity was a Series B round of $613.29 thousand completed in February 2026. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.

  • Total Funding $4.61M
  • Total Rounds 2
  • Last Round Series B β€” $613,285
  • First Round $4M

    (Sep 2019)

  • Investors Count 3

All 2 funding rounds of Flyp Nebulizer with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.

DateAmountTransaction NameValuationLead InvestorsInvestors
Feb 2026$613,285Series B––
–
Sep 2019$4MSeries B–HighCape Capital
Valuation history

3 investors in total: 3 institutional.

Investors in Flyp Nebulizer

Flyp Nebulizer has secured backing from 3 investors, including venture fund investors. Prominent investors backing the company include HighCape Capital, Connecticut Innovations and Stonehenge Capital.

All
Venture Fund
InvestorDescriptionFounded YearDomainLocation
Life science companies are targeted for private equity investments.
2013highcape.comNew York, United States
Venture capital services for biotech, IT, and innovative sectors in Connecticut.
ctinnovations.com
US private equity investments are managed by Stonehenge Capital.
stonehengecapital.comBaton Rouge, United States
Premium access

Investor details for Flyp Nebulizer

The complete investor list, round-by-round participation and investor portfolios require an active premium plan.

  • Complete investor list
  • Round participation
  • Investor portfolios
  • Co-investor network

Verified entity values are shown only after access is granted.

People of Flyp Nebulizer

1 people are tracked at Flyp Nebulizer (1 in leadership); the tracked headcount is 24.

NameRoleGroup
Ralph Finger
Founder & ChairmanLeadership
Premium access

Complete people profiles for Flyp Nebulizer

Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.

  • Full employee list
  • Team structure
  • Board tenure
  • Professional contacts

Verified entity values are shown only after access is granted.

Timeline of Flyp Nebulizer

3 dated milestones of Flyp Nebulizer across 9 years, from founding to its latest funding, stage changes and deals.

  1. Founded Flyp Nebulizer is founded.
  2. Funding First funding round of $4.0M.
  3. Funding Latest funding round, Series B, of $613K.

Competitors of Flyp Nebulizer

Flyp Nebulizer has 3 listed competitors in our database, 2 of them funded. They include Aerin Medical, SmartVest and TurnCare.

Company NameDomainFoundedHQ LocationTotal fundingEmployeesDescription
aerinmedical.com2011Sunnyvale, United States$176.4M66
Therapeutic devices for nasal breathing improvement are developed.
smartvest.com1992Saint Paul, United States137
Airway clearance system
turncare.com2011Palo Alto, United States$15.75M
Provider of perfusion enhancement system for mobility-impaired patients
Premium access

Detailed competitors of Flyp Nebulizer

The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.

  • Full competitor set
  • Operating metrics
  • Benchmarks
  • Competitive positioning

Verified entity values are shown only after access is granted.

Top companies in Pulmonology

3 companies that operate in the same segment as Flyp Nebulizer (Pulmonology) in United States, ranked by their profile score on The Company Check.

CompanyDescriptionFoundedLocationTotal fundingRevenueEmployees
Developer of novel protein-based therapeutics using machine learning and biological engineering
2018Somerville, Massachusetts, United StatesUSD 693 M329
Portable oxygen concentrators are supplied for respiratory therapy needs.
2001Goleta, California, United StatesUSD 51.65 MUSD 348.67 M766
Robotic microsurgical systems for endoscopy are developed.
2007Redwood City, California, United StatesUSD 733.62 M91
Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track β€” from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • βœ“
    Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • βœ“
    Full access to every database India & global coverage, advanced filters and rich profile details
  • βœ“
    Always-on access from your team account Single premium plan for everything you see on the portal

Related news about Flyp Nebulizer

Convexity Scientific raises $4m Series B for Flyp nebulizer
Drugdeliverybusiness β€’ 7 years ago
Premium access

Complete news archive for Flyp Nebulizer

Full article history, source details, and older brand coverage require an active premium plan.

  • Full article archive
  • Source and publication date
  • Older coverage
  • Brand-specific news history

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Flyp Nebulizer

Flyp Nebulizer was founded in 2017 and raised its 1st funding round 2 years after it was founded.

Flyp Nebulizer is headquartered in Fairfield, United States.

Flyp Nebulizer is a funded company, having raised a total of $4.61M across 2 funding rounds to date. The company's 1st funding round was a Series B of $4M, raised on Sep 2019.

Flyp Nebulizer has 24 employees.

Flyp Nebulizer was founded in 2017 and is based in Fairfield, United States. Portable nebulizers powered by HypersoniQ technology are developed by the company for asthma and COPD management. These pocket-sized, USB-rechargeable devices are designed to dispense medication efficiently. Operations focus on medical device innovation within the respiratory health sector, serving users requiring on-the-go treatment options.

Flyp Nebulizer's top competitors include Aerin Medical, SmartVest and TurnCare.

Flyp Nebulizer has 3 investors. Key investors include HighCape Capital, Connecticut Innovations, and Stonehenge Capital.

Flyp Nebulizer operates through Convexity Scientific Inc..

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available